[Evaluation of efficacy and safety of sterile solution of lodoxamide in patients with ocular allergy].
OBJECTIVE
Evaluating the efficiency and safety of Alomide (lodoxamide 01.%) in the treatment of allergic conjunctivitis. MATERIAL, METHOD: 12 patients have been selected during may-august 1998, in order to be treated with Alomide 4 times daily. The clinical exam of the patient included: general information, history, ocular examination. The ocular status of each patient has been evaluated with a score: the intensity of each symptom and sign has been graded between 1-3.


RESULTS
In all cases, the use of Alomide induced the improvement of the typical symptoms and signs of the allergic conjunctivitis. No side effect related to the use of the drug has been noted.


CONCLUSIONS
Due to its dual action (inhibition of both mast cells and eosinophils), Alomide covers most of the allergic response.
Nicoară
S
S
Clinica Oftalmologică Cluj-Napoca.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D018926:Anti-Allergic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D003233:Conjunctivitis, Allergic / Q000188:drug therapy*; D006801:Humans; D010072:Oxamic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D016896:Treatment Outcome
D018926:Anti-Allergic Agents; D010072:Oxamic Acid; C021702:lodoxamide ethyl
Evaluarea eficacităţii şi siguranţei soluţiei sterile oftalmice de lodoxamidă la pacienţii cu tulburări oculare alergice.